P-A on Reye's Syndrome
Proprietary Assn. President James Cope wrote Senate Labor and Resources Cmte. members opposing the Emergency Reye's Syndrome Prevention Act. Cope noted the voluntary label warning program is underway. He added that "there is no need for legislative label warnings because there is already adequate legal authority in the present ]FD&C Act[ to require such where scientificaiiy justified"
You may also be interested in...
Belgium’s UCB Pharma is expecting progress with new candidates for myasthenia gravis, psoriasis and osteoporosis this year.
A detailed report published by Medicines for Europe setting out policies affecting the off-patent industry across 22 European countries demonstrates the urgent need for pricing and reimbursement and procurement reforms, the association insists.
The Swiss major, which is already signed up to help produce Pfizer and BioNTech's COVID-19 vaccine, is offering its services to CureVac to produce its mRNA vaccine.